Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Rat dog micro-cap picks... -- Ignore unavailable to you. Want to Upgrade?

To: BlueCheap who wrote (6821)	1/28/2002 2:50:10 PM
From: Bucky Katt	Read Replies (2) \| Respond to of 48461

DYNT has an interesting release out today, and in this managed care world, I think it could be important. As I previously said, they will be at the Salt Lake Olympics, providing free services to the participants, and thus will receive world-wide press. (I have been accumulating shares for 3 months, in dribs & drabs, and it is finally showing t/a improvement) Been adding FONR at current levels, t/a is also improving.. Not a rat, but I bought some F last week @14.25 as I saw some heavy buying, looks like it was Morgan Stanley, they upgraded F this morn, now selling the inventory they bought where I did.... __________________________________________________________ DYNT> Dynatronics' STS Patient Study Published in American Journal of Pain Management SALT LAKE CITY, Jan. 28 /PRNewswire-FirstCall/ -- Dynatronics Corporation (Nasdaq: DYNT - news) today announced the publication of a research study assessing the effectiveness of the company's new STS technology for treating chronic pain. The study included 20 chronic pain patients who received STS treatments over a 28-day period. After the conclusion of the treatments, 85% of study participants reported an improvement in their pain of 45% or greater, and 50% percent of the subjects reported total pain relief. Entitled ``Effects of Sympathetic Therapy on Chronic Pain in Peripheral Neuropathy Subjects,'' the study was published in the January 2002 edition of the American Journal of Pain Management, a peer-reviewed medical journal. ``The publication of this study in a peer reviewed journal is a significant step in further establishing the credibility of the STS technology,'' stated Kelvyn H. Cullimore Jr., president of Dynatronics. ``With millions of people in the United States suffering from chronic pain conditions, this study supports the company's belief that a non-invasive treatment option such as the STS can be a desirable, cost-effective alternative for many chronic pain sufferers.'' The study was conducted by Ernesto Guido, M.D., A.B.P.N, a board-certified neurologist in Corpus Christi, Texas. Dr. Donald Rhodes, also of Corpus Christi, provided assistance with the study's design and execution. ``The results from this study were impressive,'' said Dr. Guido. ``Not only did most patients report dramatic pain reduction after undergoing the STS treatments, but 80 percent also reported they were sleeping better and enjoying an overall improvement in their quality of life.'' For a complete copy of the published research study, contact the American Journal of Pain Management (806-352-0781) or Dynatronics (800-874-6251). Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, pain management, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More>http://www.siliconinvestor.com/readmsg.aspx?msgid=16626164 Note the phrase, "worldwide" and "It’s spreading all over the world, and I think we haven’t even discovered all of its capabilities." Marketing & timing....